Congenital lymphedema presenting with increased nuchal translucency at 13 weeks of gestation

Prenatal Diagnosis

Volumn 22, Issue 2, 2002, Pages 91-92

  Souka, A P ^a   Krampl, E ^a   Geerts, L ^a   Nicolaides, K H ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Congenital lymphedema; Nuchal translucency

Indexed keywords

ARTICLE; AUTOSOMAL DOMINANT DISORDER; CASE REPORT; CHROMOSOME 15; FEMALE; FETUS; FETUS ECHOGRAPHY; GENE LOCUS; GESTATIONAL AGE; HUMAN; INFANT; LEG; LYMPH VESSEL; LYMPHATIC DRAINAGE; LYMPHEDEMA; PRIORITY JOURNAL;

ADULT; CROWN-RUMP LENGTH; FEMALE; FETAL DISEASES; GESTATIONAL AGE; HUMANS; LYMPHEDEMA; NECK; PREGNANCY; ULTRASONOGRAPHY, PRENATAL;

EID: 0036186049     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.104     Document Type: Article

References (9)

1. Cause of primary congenital lymphedema
2. Mapping of primary congenital lymphedema to the 5q35.3 region
3. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: Population based cohort study
4. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase
5. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development
6. Missence mutations interfere with VEGFR-3 signalling in primary lymphedema
7. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation
8. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation
9. Lymphatic vessel hypoplasia in fetuses with Turner syndrome